Beyond affecting cancer cell-intrinsic signaling, niclosamide can regulate signals communicated from other cell types in the tumor microenvironment such as adipocyte-mediated epithelial to mesenchymal transition through inhibition of the interleukin-6/STAT3 signaling axis (52). This evidence concerns the gene STAT3 and cancer.